Titan Biotech Limited
Promoter holding in Titan Biotech Limited was 55.78% in Jun 2026.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 55.78% | 44.22% |
Compared with similar companies
Promoter holding in Titan Biotech Limited is higher than 53% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Titan Biotech Limited | 55.78% |
| Krsnaa Diagnostics Limited | 27.11% |
| Fischer Medical Ventures Limited | 63.08% |
| Tarsons Products Limited | 47.30% |
| NGL Fine-Chem Limited | 72.49% |
| Hester Biosciences Limited | 44.28% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Titan Biotech Limited's promoter holding?
Promoters held 55.78% of Titan Biotech Limited as of 30 Jun 2026, and the public held 44.22%.
Are any promoter shares of Titan Biotech Limited pledged?
No promoter shares are recorded as pledged.
How does Titan Biotech Limited's promoter holding compare with similar companies?
Promoter holding in Titan Biotech Limited is higher than 53% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.